Portfolio of Biotech Stocks: Diabetes
Here is a sample of 4 biotech stocks that provide diabetes treatments.
|4 Biotech Stocks: Diabetes|
Stock & Price Chart
Recent Prices &
|Price data from Quandl as of most recent close.|
stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2009. All prices are adjusted for splits and dividends.
To inspect the performance of the Biotech Stocks: Diabetes portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $52,331. The percent return is 423.31%. The annualized return is 21.04%.